[go: up one dir, main page]

AU2001269082A1 - Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae - Google Patents

Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae

Info

Publication number
AU2001269082A1
AU2001269082A1 AU2001269082A AU6908201A AU2001269082A1 AU 2001269082 A1 AU2001269082 A1 AU 2001269082A1 AU 2001269082 A AU2001269082 A AU 2001269082A AU 6908201 A AU6908201 A AU 6908201A AU 2001269082 A1 AU2001269082 A1 AU 2001269082A1
Authority
AU
Australia
Prior art keywords
flaviviridae
treating
infections caused
preventing infections
phyllanthus constituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269082A
Inventor
Robert H. M. Van Der Giessen
Christoph Von Keudell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CMI-CENTERS FOR MEDICAL INNOVATION AG
Original Assignee
CMI AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CMI AG filed Critical CMI AG
Publication of AU2001269082A1 publication Critical patent/AU2001269082A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001269082A 2000-06-20 2001-06-20 Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae Abandoned AU2001269082A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10030139A DE10030139A1 (en) 2000-06-20 2000-06-20 Use of phyllanthus components for the treatment or prophylaxis of Flaviviridae infections
DE10030139 2000-06-20
PCT/EP2001/006981 WO2001097824A2 (en) 2000-06-20 2001-06-20 Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae

Publications (1)

Publication Number Publication Date
AU2001269082A1 true AU2001269082A1 (en) 2002-01-02

Family

ID=7646244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269082A Abandoned AU2001269082A1 (en) 2000-06-20 2001-06-20 Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae

Country Status (6)

Country Link
US (2) US20040028754A1 (en)
EP (1) EP1294387A2 (en)
AU (1) AU2001269082A1 (en)
CA (1) CA2413331A1 (en)
DE (1) DE10030139A1 (en)
WO (1) WO2001097824A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE275413T1 (en) 2000-10-06 2004-09-15 Phytrix Ag METHOD FOR PRODUCING PHYLLANTHUS EXTRACTS
DE10120627A1 (en) * 2001-04-26 2002-10-31 Cmi Ag Use of phyllanthus components for the treatment or prophylaxis of infections caused by hepatitis B viruses
WO2007044468A2 (en) * 2005-10-05 2007-04-19 The Cbr Institute For Biomedical Research, Inc. Method to treat flavivirus infection with sirna
US20070196381A1 (en) * 2006-02-17 2007-08-23 Natures Benefit, Inc. Herbal compositions, methods of stimulating immunomodulation and enhancement of immunomodulating agents using the herbal compositions
US20080182895A1 (en) * 2006-08-25 2008-07-31 Howe Anita Y M Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto
KR101105889B1 (en) 2009-09-29 2012-01-16 주식회사 바이오엔그린텍 Diarrhea prevention and treatment composition of livestock comprising herbal extract as an active ingredient and method for producing same
US20130122119A1 (en) * 2011-11-01 2013-05-16 Natreon, Inc. Phyllanthus amarus compositions and method of extracting same
KR101537468B1 (en) * 2014-01-16 2015-07-16 성균관대학교산학협력단 Pharmaceutical compositions preventing or treating inflammatory diseases comprising extract of phyllanthus acidus
CN111529566A (en) * 2020-06-11 2020-08-14 广东盛普生命科技有限公司 Antiviral spray and preparation method and application thereof
CN111529565A (en) * 2020-06-11 2020-08-14 广东盛普生命科技有限公司 Preparation for resisting influenza virus and preparation method and application thereof
CN111494452A (en) * 2020-06-11 2020-08-07 广东盛普生命科技有限公司 Eye medicine and its preparing method
CN111588744A (en) * 2020-06-11 2020-08-28 广东盛普生命科技有限公司 Antiviral composition and oral liquid as well as preparation method and application thereof
EP3954379A1 (en) * 2020-08-12 2022-02-16 HFM - Hybrid Fusion Medicals, GmbH Compositions comprising phyllanthus extract for use in the treatment or prevention of a sars-cov-2 infection and/or at least one symptom of covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33275A (en) * 1861-09-10 Improved pipe-joi-nt
US161477A (en) * 1875-03-30 Improvement in curtain-fixtures
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
US4937074A (en) * 1988-03-29 1990-06-26 Fox Chase Cancer Center Method of treating retrovirus infection
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
US5648089A (en) * 1995-07-03 1997-07-15 Shawkat; Tarek Extract solution and herbal mixture for treatment of hepatitis
US6136316A (en) * 1996-04-17 2000-10-24 Dabur Research Foundation Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
US6589570B1 (en) * 1999-04-12 2003-07-08 University Of Madras Pharmaceutical formulation useful for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation
DE19919585A1 (en) * 1999-04-29 2000-12-07 Cmi Ag Use of phyllanthus to treat oxidative stress and other symptoms

Also Published As

Publication number Publication date
US20040028754A1 (en) 2004-02-12
WO2001097824A3 (en) 2002-05-10
US20020054921A1 (en) 2002-05-09
WO2001097824A2 (en) 2001-12-27
EP1294387A2 (en) 2003-03-26
DE10030139A1 (en) 2002-01-10
CA2413331A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
GB0125222D0 (en) Composition for the treatment of microbial infections
PL364995A1 (en) Method for the treatment or prevention of flavivirus
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
PL376409A1 (en) Composition for the treatment of infection by flaviviridae viruses
AP2005003213A0 (en) 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
DK1117401T3 (en) Antibiotic preparation for eye treatment
AU2001233081A1 (en) Composition for treatment of stress
PL365453A1 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2002232558A1 (en) Compounds, compositions and methods for treatment of parasitic infections
AU2001269082A1 (en) Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae
AU2002336405A1 (en) Methods for treating deodorizer distillate
AU2001277862A1 (en) Improving effectiveness of introaocular lenses by gcib
EP1626692A4 (en) Compounds for the treatment of flaviviridae infections
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001286983A1 (en) Method of treatment
AU2002232400A1 (en) Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2002302580A1 (en) Use of phyllanthus constituents for treating or preventing infections caused by hepatit
DE60005566D1 (en) PYRANOINDOLS FOR Glaucoma Treatment
AU2001262177A1 (en) Method of treatment
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2001281465A1 (en) Treatment of rosacea

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 51135/00, 55739/00, 55753/00, 58352/00, 64779/00, 11766/01, 14201/01, 18556/01, 20246/01, 20294/01, 22332/01, 35823/01, 36156/01, 37182/01, 46369/01, 48208/01, 48315/01, 50679/01, 52085/01, 52276/01, 56642/01, 60274/01, 60568/01, 60778/01, 62458/01, 62772/01, 62800/01, 64365/01, 65683/01, 66404/01, 67663/01, 69082/01, 69203/01, 69256/01, 69635/01, 69646/01, 70658/01, 70666/01, 74025/01, 74137/01, 74164/01, 74182/01, 74196/01, 74638/01, 75606/01, 77459/01 AND 78421/01